King Pharmaceuticals KG Change in loss reserves
Change in loss reserves at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve.
The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's change in loss reserves.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is King Pharmaceuticals's change in loss reserves?
- King Pharmaceuticals (KG) reported change in loss reserves of -$16.74M in Q1 2026.
- What does change in loss reserves mean?
- The net change in the estimated liability for insurance claims that have been incurred but not yet settled. This reflects the company's underwriting performance and the accuracy of its actuarial projections regarding future claim costs. Significant changes in this reserve can indicate shifts in underwriting risk or the emergence of unexpected claim trends.